FindTrial
Sign In

To measure the levels of 2 biomarkers in early pregnancy and its association with adverse pregnancy outcomes

Homocysteine and Asymmetric Dimethyl Arginine(ADMA)levels in early pregnancy and pregnancy outcome- a descriptive observational study at teaching hospital attached to KLE Universitys J N medical college, Belagavi

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/02/007821
Enrollment
200
Registered
2017-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O281- Abnormal biochemical finding on antenatal screening of mother

Interventions

None listed

Sponsors

Dr Belide Shruthi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)singleton pregnancy 2)gestational age less than or equal to 18weeks 3)willing to deliver at teaching hospital attached to KLE Universitys J N Medical college,Belagavi.

Exclusion criteria

Exclusion criteria: 1)known case of hypertension 2)known case of overt diabetes mellitus 3)known case of renal/liver disorders

Design outcomes

Primary

MeasureTime frame
to measure the levels of homocysteine and asymmetric dimethyl arginine in early pregnancy in this region.Timepoint: early pregnancy(less than or equal to 18 weeks gestation)—

Secondary

MeasureTime frame
any adverse pregnancy outcomes like gestational hypertension, pre-eclampsia, eclampsia, preterm birth, fetal growth restriction, stillbirth, miscarriage, abruptio placenta.Timepoint: at the time of termination of pregnancy.—

Countries

India

Contacts

Public ContactDr Belide Shruthi

KLE Universitys J N Medical college

mbbellad@hotmail.com9448124893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026